IDEAL PATIENT REGISTRY Trademark

Trademark Overview

On Thursday, December 9, 2010, a trademark application was filed for IDEAL PATIENT REGISTRY with the United States Patent and Trademark Office. The USPTO has given the IDEAL PATIENT REGISTRY trademark a serial number of 85194581. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 5, 2023. This trademark is owned by Coram, Inc.. The IDEAL PATIENT REGISTRY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, studies relating to patients treated with immunoglobulin; scientific study and research in the field of immunoglobulin; [ providing an on-line searchable database featuring medical and scientific research, including clinical trials, concerning immunoglobulin patients and therapies; ] providing information on medical and scientific research concerning immunoglobulin patients and therapies; providing medical and scientific research information in the field of clinical trials; providing medical research and scientific research information in the field of immunoglobulin clinical trials
ideal patient registry

General Information

Serial Number85194581
Word MarkIDEAL PATIENT REGISTRY
Filing DateThursday, December 9, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 5, 2023
Registration Number4188791
Registration DateTuesday, August 14, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2012

Trademark Statements

Pseudo MarkIMMUNOGLOBULIN, DIAGNOSIS, EVALUATION, AND KEY LEARNINGS PATIENT REGISTRY
Disclaimer with Predetermined Text"PATIENT REGISTRY"
Goods and ServicesMedical and scientific research, namely, studies relating to patients treated with immunoglobulin; scientific study and research in the field of immunoglobulin; [ providing an on-line searchable database featuring medical and scientific research, including clinical trials, concerning immunoglobulin patients and therapies; ] providing information on medical and scientific research concerning immunoglobulin patients and therapies; providing medical and scientific research information in the field of clinical trials; providing medical research and scientific research information in the field of immunoglobulin clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 14, 2010
Primary Code042
First Use Anywhere DateTuesday, December 15, 2009
First Use In Commerce DateTuesday, December 15, 2009

Trademark Owner History

Party NameCoram LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWoonsocket, RI 02895
Party NameCoram, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDenver, CO 80202
Party NameCoram, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDenver, CO 80202
Party NameCoram, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDenver, CO 80202

Trademark Events

Event DateEvent Description
Thursday, January 5, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 5, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 5, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 5, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 16, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, August 14, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 13, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, August 13, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 13, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 6, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, August 14, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, January 26, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 26, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 14, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 10, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 10, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 5, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 15, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 14, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, July 11, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 29, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 24, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 24, 2012ASSIGNED TO LIE
Wednesday, April 4, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 31, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 2, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 31, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, December 8, 2011ASSIGNED TO EXAMINER
Friday, October 7, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 7, 2011FINAL REFUSAL E-MAILED
Friday, October 7, 2011FINAL REFUSAL WRITTEN
Saturday, September 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 16, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 16, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2011NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2011NON-FINAL ACTION WRITTEN
Monday, March 14, 2011ASSIGNED TO EXAMINER
Tuesday, December 14, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 13, 2010NEW APPLICATION ENTERED

Related Keywords

registry patient ideal research scientific immunoglobulin medical providing information trials clinical field patients